Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year debt growth rate
Percentile
P13
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.71% |
| Q3 2025 | -1.27% |
| Q2 2025 | -1.03% |
| Q1 2025 | -7.80% |
| Q4 2024 | -26.20% |
| Q3 2024 | -3.36% |
| Q2 2024 | -3.18% |
| Q1 2024 | 11.21% |
| Q4 2023 | -4.55% |
| Q3 2023 | -1.53% |
| Q2 2023 | -3.02% |
| Q1 2023 | -2.60% |
| Q4 2022 | 6.66% |
| Q3 2022 | -0.45% |
| Q2 2022 | 0.73% |
| Q1 2022 | 11.69% |
| Q4 2021 | -1.13% |
| Q3 2021 | 38.40% |
| Q2 2021 | -3.20% |
| Q1 2021 | 4.53% |
| Q4 2020 | 373.63% |
| Q3 2020 | 38.52% |
| Q2 2020 | -17.28% |
| Q1 2020 | -17.23% |
| Q4 2019 | -20.07% |
| Q3 2019 | 18.93% |
| Q2 2019 | 15.88% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |